The aim of this study was to examine the ability of Pseudomonas aeruginosa components to induce release of cytokines from human leukocytes. Human whole-blood cultures were incubated with several concentrations of purified P. aeruginosa products, including porins, exomucopolysaccharide, lipopolysaccharide, and toxin A. Supernatants were assayed for tumor necrosis factor alpha (TNF-␣) and interleukin-6 (IL-6) activities. All of the P. aeruginosa components except toxin A were able to stimulate the release of both cytokines. On a weight basis, porins were as effective as lipopolysaccharide and significantly more effective than exomucopolysaccharide in inducing IL-6 release (P < 0.05). Moreover, porins were more potent than either exomucopolysaccharide or lipopolysaccharide in inducing TNF-␣ release (P < 0.05). Further experiments using isolated leukocytes suggested that monocytes were the cell population predominantly responsible for the production of both cytokines. These data indicate that P. aeruginosa porins are able to induce significant cytokine production. These components may be responsible for the chronically overactive inflammatory response associated with persistent lung infection in cystic fibrosis patients.
The chronically overactive inflammatory response associated with persistent Pseudomonas aeruginosa lung infections of cystic fibrosis (CF) patients is believed to be caused by the continuous stimulation of host cells to produce cytokines (7, 17, 24, 37) . Indeed, high cytokine levels have been found in blood and sputa of CF patients, especially in the terminal stages of the disease (17, 24) . Chemotaxis and overactivation of neutrophils caused by macrophage-derived cytokines are features of the inflammation in CF patients (7, 17) . Upon activation, neutrophils release oxygen radicals and lysosomal protease enzymes as well as small amounts of elastase, which have the potential to cause tissue damage (3, 5, 8, 30) .
It is of interest, therefore, to identify the P. aeruginosa compounds that are capable of stimulating leukocytes to release cytokines. A number of components, including lipopolysaccharide (LPS) and mucoid exopolysaccharide (MEP), have been shown to stimulate macrophages to release mediators such as tumor necrosis factor alpha (TNF-␣), interleukin-8 (IL-8), leukotriene B4, and platelet-activating factor (18, 26, 27) . Toxin A at very low, noncytotoxic concentrations is able to induce the proliferation of murine thymocytes and IL-1 release by murine peritoneal macrophages (20, 21) .
The outer membrane layer of the cell wall of gram-negative bacteria contains hydrophobic proteins (29) that are called porins because they form transmembrane channels allowing passive diffusion of solutes across the outer membrane (23) . Porins are in trimeric form in the membrane (2) and may be released either during cell growth or during bacteriolysis (22) . Given their resistance to proteolysis (16), they are not degraded and may insert in the plasma membrane of host cells (31) . Depending on the dose, porins may be cytotoxic for target cells or may interfere with cell functions (11) . These proteins were found to significantly affect a number of host defense mechanisms, including phagocytosis, oxidase burst, and chemotaxis of polymorphonuclear leukocytes (PMN).
In view of studies showing that outer membrane porins of a number of gram-negative pathogens, including Salmonella typhimurium, Yersinia enterocolitica, and Helicobacter pylori, are capable of stimulating human leukocytes to release cytokines (14, 31, 32, (34) (35) (36) , we decided to examine the abilities of P. aeruginosa porins (15) to cause such stimulation.
Specifically, porins, LPS, MEP, and toxin A from P. aeruginosa were compared for their abilities to stimulate human leukocytes to release TNF-␣ and IL-6. We focused on TNF-␣ since this is a potent mediator of inflammation and is the first cytokine to be released after interaction of host cells with a variety of microbial products (6, 40) . In addition, we were interested in studying IL-6 production since this cytokine is induced by TNF-␣ and provides, in turn, a negative feedback signal by down regulating TNF-␣ and IL-1 (1, 19, 39) .
MATERIALS AND METHODS
Purified P. aeruginosa components. A mucoid strain isolated in our laboratory from the sputum of a CF patient was used in this study. Porins were purified by the method of Nurminen (25) from bacteria grown in nutrient broth to the late log phase. Two batches of porins were prepared by identical methods. Briefly, 1 g of envelope was treated with 2% Triton X-100 in 0.01 M Tris-HCl (pH 7.5) containing 10 mM EDTA. After the addition of trypsin (10 mg/g of envelope), the pellet was dissolved in sodium dodecyl sulfate (SDS) buffer (4% [wt/vol] in 0.1 M sodium phosphate [pH 7.2]) and applied to an Ultrogel ACA34 column equilibrated with 0.25% SDS buffer. The protein-rich fraction, consisting of porins, was extensively dialyzed and lyophilized. The method yielded approximately 0.7 mg of porins per 10 g (wet weight) of P. aeruginosa. Endotoxin contamination of the porin preparations was found to be less than 0.01%, as assayed by the Limulus amebocyte test. SDS was present in traces (0.01 g/20 g of porins) in the final preparation. SDS-polyacrylamide gel electrophoresis of purified porin preparations showed one band of 36 to 38 kDa (Fig. 1) .
The method described by Evans and Linker (10) was used to extract and purify MEP. Briefly, after a 4-day culture at 25ЊC on MacConkey agar plates modified by the addition of 3% (vol/vol) glycerol, surface growth was removed and placed in 25 volumes of sterile 0.9% saline. The suspension was stirred until a uniform appearance was observed and then centrifuged at 20,000 ϫ g for 60 min. The supernatant was recentrifuged at the same speed for another 2 h and then treated by the slow addition of 3 volumes of 95% ethanol. The precipitate was recovered by centrifugation at 3,000 ϫ g for 30 min and washed with 95% ethanol twice and pure ethanol once.
Further purification of MEP was accomplished by dissolution in 0.1 M Tris buffer (pH 7.4) at a concentration of 5 mg/ml followed by the addition of 1 mg of pronase (Sigma Chimica, Milan, Italy) per ml. After incubation at 37ЊC for 48 h, the mixture was dialyzed for 17 h against two changes of 40 volumes each of distilled water and centrifuged at 20,000 ϫ g for 2 h to remove formal precipitates. The supernatant was removed, and sodium acetate was added to a final concentration of 0.5%, after which the supernatant was treated with 3 volumes of 95% ethanol to precipitate MEP. After further treatments with 80%-95% pure ethanol-ether, the supernatant was dried to obtain the final MEP preparation. Contamination of the latter was found to be less than 0.01% for LPS (as assayed by the Limulus amebocyte test) and less than 0.5% for proteins and nucleic acids, as measured by A 280 and A 260 , respectively.
Purified toxin A (ICN Biomedical, Milan, Italy) was dissolved in RPMI 1640 medium. The same batch of toxin A was used throughout the experiments. In view of its high toxicity, in preliminary experiments toxin A cytotoxicity was assayed by using the trypan blue exclusion test. To assess the cytokine-inducing abilities of toxin A, noncytotoxic concentrations were used in our experiments. LPS from P. aeruginosa (serotype 10) and from Salmonella enteritidis were purchased from Sigma Chimica.
Whole-blood cultures. Whole peripheral blood was obtained from healthy volunteers and mixed with equal volumes of RPMI 1640 containing 20 U of heparin per ml. Volumes of 1 ml were dispensed to 24-well plates and incubated at 37ЊC for 18 h in 5% CO 2 with the indicated amounts of P. aeruginosa components. LPS (100 ng/ml) from S. enteritidis was used as a positive control. Cultures were then centrifuged (600 ϫ g for 15 min), and the supernatants were stored at Ϫ70ЊC until tested for cytokine concentrations.
Isolated leukocyte cultures. Whole blood, obtained as described above, was sedimented in the presence of 5% dextran, and the leukocyte-rich plasma was centrifuged at 200 ϫ g for 10 min. Leukocytes were washed three times, resuspended in RPMI 1640, and centrifuged (400 ϫ g for 30 min) over Ficoll-Hypaque gradients. Peripheral blood mononuclear cells (PBMN) and PMN were obtained from the interface and the pellet, respectively. In further experiments, PBMN were separated in adherent and nonadherent populations by incubation in plastic tissue culture dishes for 2 h at 37ЊC. Adherent and nonadherent PBMN were Ͼ90% monocytes and lymphocytes, respectively, by morphology. Immunofluorescence analysis using fluorescein-conjugated polyvalent rabbit anti-human immunoglobulin G (Sigma) indicated that B cells comprised Ͻ4% of adherent PBMN. To assess cytokine production, 2 ϫ 10 6 separated or unseparated leukocytes were cultured for 18 h in RPMI 1640 containing 10% autologous plasma with the indicated concentrations of P. aeruginosa components.
Measurements of TNF-␣ and IL-6. TNF-␣-sensitive WEHI clone 13 cells were cultured for 8 h at 37ЊC in 5% CO 2 in 96-well flat-bottom tissue culture plates. Medium was then removed and replaced with test sample or standard TNF-␣ preparations containing actinomycin D (3 g/ml). The plates were incubated for 24 h, and the supernatants were removed. The cells were then stained with 0.5% crystal violet in 20% methanol for 15 min and washed in tap water. After drying, the dye was solubilized by addition of 0.1% SDS/well for 1 h at 37ЊC. The A 540 was determined by using a microtiter plate reader, and titers were expressed as units/milliliter. One unit was defined as the amount of TNF-␣ causing 50% lysis of WEHI cells. TNF-␣ activity in selected plasma samples was totally inhibited by a 1:100 dilution of anti TNF-␣ serum but not by normal serum. To exclude that cytotoxicity was due to a direct effect of the porins, in preliminary experiments, WEHI clone 13 cells were incubated with the highest concentration (10 g/ml) of porins used in our experiments. No cytotoxic effects were observed under these conditions. IL-6 was measured by using the IL-6-dependent 7TD1 hybridoma proliferation assay. Briefly, standards or diluted supernatants were mixed with 7TD1 cells (2 ϫ 10 5 cells per ml) and cultured for 3 days in microtiter plates. Ten serial twofold dilutions were tested for each supernatant sample. Final dilutions ranged from 1:10 to 1:5,120. Cell proliferation was assessed by a colorimetric method using 100 g of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; thiazolyl blue; Sigma) per well. After a 3-h incubation, the reduced dye was solubilized by the addition of a mixture of 20% SDS/well and 50% dimethylformamide in H 2 O. A microtiter plate reader was used to measure A 570 . One unit of IL-6 was defined as the amount that induced 50% maximal proliferation. The assay was calibrated by using murine recombinant IL-6 as a standard. The lower limits of detection of the assay were 2 and 4 U/ml for TNF-␣ and IL-6, respectively, taking into account sample dilution (38) .
Data expression and statistical analysis. Data are expressed as means Ϯ standard deviations (SD) of four separate experiments, each performed in duplicate with cells from different donors. Statistical significance was assessed by one-way analysis of variance and the Student-Keuls-Newman test.
RESULTS
TNF-␣ and IL-6 production in whole blood. To study the cytokine-inducing activities of P. aeruginosa components, LPS, MEP, toxin A, and porins were added in increasing concentrations to whole-blood cultures, and supernatants were tested for TNF-␣ and IL-6. S. enteritidis LPS (0.1 g/ml) was used as positive control.
TNF-␣ was not detected in unstimulated or toxin A-stimulated cultures (10 or 100 ng/ml; data not shown). All of the other P. aeruginosa compounds tested were capable of inducing dose-dependent TNF-␣ release (Fig. 2) . At 5 or 10 g/ml, porins stimulated significantly higher TNF-␣ release than MEP or P. aeruginosa LPS (P Ͻ 0.05). Maximal porin-induced TNF-␣ release was observed with 10 g/ml and was similar to that induced by the positive control (S. enteritidis LPS). P. aeruginosa LPS and MEP had similar TNF-␣-inducing abilities (Fig. 2) .
Low (Ͻ35 U/ml) levels of IL-6 were measured in unstimulated or toxin A-stimulated cultures (10 or 100 ng/ml; data not shown). As with TNF-␣, P. aeruginosa porins, MEP, and LPS were all capable of inducing dose-dependent IL-6 production (Fig. 3) . P. aeruginosa LPS and porins produced similar IL-6 elevations. Maximal porin or LPS-induced IL-6 release was observed with 10 g/ml. At all tested concentrations, MEP induced significantly lower IL-6 levels relative to P. aeruginosa LPS and porins (Fig. 3) .
To rule out contamination of porin and MEP preparations with LPS, the endotoxin-inactivating agent polymyxin B (25 g/ml) was added to whole-blood cultures in selected experiments. Polymyxin B addition did not affect cytokine levels induced by porins and MEP (data not shown). In additional experiments, we sought to further rule out endotoxin contamination of porins as a cause of cytokine induction by observing the effects of heating (121ЊC for 1 h). It was anticipated that such treatment would effectively denature proteins, such as porins, but not LPS. As expected, significant TNF-␣ or IL-6 elevations were not detected in supernatants of blood cultures stimulated with the heat-treated porin preparation, while the same treatment did not affect the cytokine-inducing ability of P. aeruginosa LPS (data not shown).
Leukocyte types responsible for cytokine release. Cytokineproducing cells in human blood comprise granulocytes, monocytes, T and B lymphocytes, and natural killer cells. To identify the cell types which are predominantly responsible for the cytokine responses observed in whole blood, leukocytes where centrifuged over Ficoll-Hypaque gradients and PBMN were compared with PMN for the ability to produce TNF-␣ or IL-6. Unseparated leukocytes, PBMN, and PMN were cultured in the presence of 10% autologous plasma and optimal stimulating concentrations of P. aeruginosa components. Under these conditions, PMN released smaller amounts of both cytokines, relative to unseparated leukocytes or PBMN, in response to any of the tested agents (Fig. 4 and 5 ). Since these data indicated the cell populations responsible for most TNF-␣ or IL-6 production were predominantly contained in the PBMN fraction, the latter were further separated by adherence to plastic. Most of the TNF-␣-or IL-6-producing activity was found in the adherent cell population. These data indicate that monocytes are predominantly responsible for cytokine release in response to P. aeruginosa components (Fig. 4 and 5) .
Kinetics of IL-6 and TNF-␣ release. Optimal doses of P. aeruginosa components were used to study kinetics of TNF-␣ and IL-6 secretion. The kinetics of TNF-␣ or IL-6 production by human leukocytes were similar with all of the three compounds tested. Cytokine production was already detectable at 2 h and reached maximal levels at 8 h, remaining unchanged thereafter (Fig. 6 ).
DISCUSSION
It is believed that proinflammatory cytokines, particularly IL-1, IL-8, and TNF-␣, play important roles in producing tissue damage in the lungs of CF patients (7, 17, 24, 37) . In the terminal stages of CF, high levels of cytokines have been observed in blood and sputum (17, 24) . This mediator production is the result of cell stimulation by P. aeruginosa products. It is important, therefore, to identify P. aeruginosa compounds predominantly responsible for stimulating cytokine release. Some P. aeruginosa components, including LPS, MEP, and toxin A, were previously shown to stimulate macrophages to release such mediators (18, 20, 21, 26, 27) .
In this study, we focused on the cytokine-inducing activities of porins. For comparative purposes, we also studied P. aeruginosa LPS, MEP, and toxin A. The results obtained show that P. aeruginosa porins were significantly more effective, on a weight basis, than any of the other compounds tested in inducing TNF-␣ production. Maximal TNF-␣ release induced by porins was higher than that induced by either MEP or P. aeruginosa LPS. As for IL-6 induction, porins were as effective as P. aeruginosa LPS and more effective than MEP.
It is unlikely that the observed porin-induced cytokine production was due to contamination with endotoxin. First, the VOL. 65, 1997 RELEASE OF TNF-␣ AND IL-2 INDUCED BY P. AERUGINOSA PORINSpreparations used did not contain significant endotoxin levels as assessed by a sensitive Limulus amebocyte assay. Second, the biological activity of porins was not inhibited by polymyxin B, a known endotoxin-inactivating agent. Third, heating at 121ЊC for 1 h, a procedure known to effectively denature proteins, but not LPS, completely abrogated the cytokine-inducing activities of our protein preparation. LPS has been classically considered predominantly responsible for cytokine induction by gram-negative bacteria. Recent studies, however, have indicated that other components of gram-negative, as well as gram-positive, bacteria are potent cytokine inducers. Results presented here confirm those of previous studies indicating that porins can stimulate marked cytokine release. Indeed, P. aeruginosa porins were, on a weight basis, as potent as S. typhimurium or H. pylori porins in TNF-␣ induction (data not shown). Our data are compatible with the knowledge that porins are capable of affecting a number of different host defense mechanisms (12, 14, 31, 32, (34) (35) (36) . The mechanisms of action of these agents are largely unknown and future studies should address this important point.
In conclusion, we have shown here that P. aeruginosa porins are able to induce significant cytokine production. These data may be clinically relevant since porins can be released during bacterial growth and cellular lysis and can interact with host cells. Thus, it is possible that these products contribute significantly to the pathogenesis of P. aeruginosa infection in CF patients, by inducing proinflammatory cytokines leading to the release of tissue-damaging agents. Additional studies will be needed to further assess the role of P. aeruginosa porins in the pathogenesis of lung damage in CF patients.
